and related breakdown
42% of all OPIS studies conducted between 2007 and 2015 were in Oncology and Onco-hematology.
Onco-Hematology indications include Leukemia, Lymphoma, Myeloma and Myelofibrosis.
Hematology indications include Anemia, Mastocytosis, Thalassemia, Drepanocytosis, Hemophilia, Hypereosinophilic syndrome, Idiopathic thrombocytopenic purpura, Polycythemia vera, Aplasia, Hemosiderosis and Von Willebrand disease.
47 % of studies conducted between 2007 and 2015 were in Multiple Sclerosis and other indications include Parkinson’s disease, Alzheimer’s disease, Vascular dementia, Acute demyelinating optic neuritis and Epilepsy.
Pulmonary / Respiratory Diseases
Indications include Pulmonary arterial hypertension, Lymphangioleiomyomatosis, IPF, Chronic obstructive pulmonary disease and Asthma.
Indications include Psoriaticarthritis, Juvenile idiopathic arthritis, Rheumatoid arthritis, Spondylo arthritis and
Organ transplant studies included heart, liver and kidney transplants.
Metabolism and Nutritional Disorders
Main experience in Diabetes studies. More than 80% of studies conducted in Diabetes. Other indications include Metabolic syndrome, Mixed dyslipidemia and Obesity.
2007-2015 / Experience based on more than 1000 trials
Other Areas of Expertise
In addition to our experience in main pharmaceutical therapeutic areas, we have also conducted a number of clinical trials in other areas, including:
Infections and infectious diseases
Dental and oral health